All Studies

Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest.

PM, a traditional Chinese medicine, shows potential as a treatment for prostate cancer by suppressing cancer growth in an AR-dependent manner. This study investigates its anti-tumor mechanism in advanced prostate cancer.

Zhou Q et al (2024).
Bioorg Chem.
PubMed:
39180863

Unveiling promising phytocompounds from Moringa oleifera as dual inhibitors of EGFR((T790M/C797S)) and VEGFR-2 in non-small cell lung cancer through in silico screening, ADMET, dynamics simulation, and DFT analysis.

Researchers identified five compounds from Moringa oleifera plant with strong potential as dual-acting drugs for treating NSCLC by targeting EGFR and VEGFR-2. Hesperetin, gossypetin, and quercetagetin show the most promise.

Masudur Rahman Munna M et al (2024).
J Genet Eng Biotechnol.
PubMed:
39179328

Antiviral activity of Morus alba L. extract against pseudorabies virus.

Scientists studied Morus alba L. for its antiviral properties against various viruses. It shows potential against influenza and SARS-CoV-2, but more research is needed for pseudorabies virus.

Zhang X et al (2024).
J Ethnopharmacol.
PubMed:
39179057

Exploring the therapeutic potential of Potentilla fragarioides var. major (Rosaceae) extract in Alzheimer's disease using in vitro and in vivo models: A multi-faceted approach.

EEPF from Potentilla fragarioides var. major inhibits Aβ aggregation, enhances free-radical scavenging, and alleviates memory impairment in AD models through multiple mechanisms. Promising potential for AD treatment.

Sohn E et al (2024).
Neuroscience.
PubMed:
39179018